Furthermore, based on the closed correlation between excessive fructose intake, insulin resistance, and NAFLD, several studies indicated that metformin, an AMPK activator, might have therapeutic potential on liver steatosis [30]. The gene discussed is PRKAA1; the disease is Hepatic steatosis.